Brief: Zynerba Pharma Reports Q4 Loss Per Share Of $0.33

Zynerba Pharmaceuticals

10/03/2021 12:17

March 10 (Reuters) - Zynerba Pharmaceuticals Inc  ZYNE.O :
    * ZYNERBA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR
2020 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
    * Q4 LOSS PER SHARE $0.33
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.33 -- REFINITIV IBES
DATA
    * AS OF DEC 31, 2020, CASH AND CASH EQUIVALENTS WERE $59.2
MILLION
    * ZYNERBA PHARMACEUTICALS - BELIEVES CASH, EQUIVALENTS,
$42.2
MILLION IN NET PROCEEDS, ARE SUFFICIENT TO FUND OPERATIONS,
CAPITAL NEEDS WELL INTO H1 OF 2024

Source text for Eikon:  ID:nGNX2vFhkj 
Further company coverage:  ZYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))